Evidence map›Paper›PMID 37615937›Full record

ArticleThe Journal of experimental medicine2023

Trained immunity of alveolar macrophages enhances injury resolution via KLF4-MERTK-mediated efferocytosis.

Sreeparna Chakraborty, Abhalaxmi Singh, Li Wang, Xinge Wang, Mark A Sanborn, Zijing Ye, Mark Maienschein-Cline, Amitabha Mukhopadhyay, Balaji B Ganesh, Asrar B Malik and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 77 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Myeloid cell reprogramming drives enhanced defense againstbioRxiv : the preprint server for biology · 2026
    Article
  8. Article
  9. Journal of medical microbiology · 2026
    Article
  10. Article
  11. Review
  12. Trained immunity in respiratory diseases: Mechanisms of action and intervention strategies.Chinese medical journal pulmonary and critical care medicine · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Frontiers in cellular and infection microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Sreeparna ChakrabortyDepartment of Biochemistry and Molecular Genetics, University of Illinois College of Medicine, Chicago, IL, USA.ORCID 0000-0003-4859-0524
Abhalaxmi SinghDepartment of Pharmacology and Regenerative Medicine, University of Illinois College of Medicine, Chicago, IL, USA.ORCID 0000-0003-0407-3154
Li WangDepartment of Biochemistry and Molecular Genetics, University of Illinois College of Medicine, Chicago, IL, USA.ORCID 0009-0008-8376-1556
Xinge WangDepartment of Biochemistry and Molecular Genetics, University of Illinois College of Medicine, Chicago, IL, USA.ORCID 0000-0003-0028-8510
Mark A SanbornDepartment of Biochemistry and Molecular Genetics, University of Illinois College of Medicine, Chicago, IL, USA.ORCID 0000-0001-5308-4680
Zijing YeDepartment of Biochemistry and Molecular Genetics, University of Illinois College of Medicine, Chicago, IL, USA.ORCID 0000-0003-4983-2329
Mark Maienschein-ClineResearch Resources Center, University of Illinois Chicago , Chicago, Illinois, USA.ORCID 0000-0001-6619-6788
Amitabha MukhopadhyayDepartment of Pharmacology and Regenerative Medicine, University of Illinois College of Medicine, Chicago, IL, USA.ORCID 0000-0003-1081-8941
Balaji B GaneshResearch Resources Center, University of Illinois Chicago , Chicago, Illinois, USA.ORCID 0000-0001-8966-6164
Asrar B MalikDepartment of Pharmacology and Regenerative Medicine, University of Illinois College of Medicine, Chicago, IL, USA.ORCID 0000-0002-8205-7128
Jalees RehmanDepartment of Biochemistry and Molecular Genetics, University of Illinois College of Medicine, Chicago, IL, USA.ORCID 0000-0002-2787-9292
Illinois College · USUniversity of Illinois Chicago · US

Funding

Synthetic Biology and Optogenetics CoreP01HL151327 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MEHTA, DOLLY · 2021 to 2025
$11.8M
Mechanisms and Treatment of SARS-CoV-2 induced Lung Endothelial InjuryR01HL162308 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI REHMAN, JALEES, RICHNER, JUSTIN · 2022 to 2025
$2.9M
iPSC-Derived Vascularized Human Lung Organoids and Interaction Between Lung Endothelial Cells and Alveolar Epithelial CellsR01HL163978 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KADUR LAKSHMINARASIM, PREETISH, REHMAN, JALEES · 2022 to 2025
$2.9M
Nanoparticle Targeting of Neutrophil Subpopulations in Inflammatory Lung InjuryR01HL149300 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MALIK, ASRAR B., REHMAN, JALEES · 2019 to 2022
$2.4M
Amplification Mechanisms of Lung Endothelial Inflammation During Acute Lung InjuryR01HL152515 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI REHMAN, JALEES · 2021 to 2024
$2.3M
Training Program in Personalized Cardiovascular Medicine (TPIPCVM)T32HL139439 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DARBAR, DAWOOD · 2018 to 2022
$2.1M
Endothelial Instruction of Macrophage Fate in Inflammatory InjuryR01HL154538 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI REHMAN, JALEES · 2021 to 2021
$128k
NHLBI NIH HHS P01 HL151327NHLBI NIH HHS R01 HL149300NHLBI NIH HHS R01 HL152515NHLBI NIH HHS R01 HL154538NHLBI NIH HHS R01 HL162308NHLBI NIH HHS R01 HL163978NHLBI NIH HHS T32 HL139439
6 · The paper itself

Abstract

Recent studies suggest that training of innate immune cells such as tissue-resident macrophages by repeated noxious stimuli can heighten host defense responses. However, it remains unclear whether trained immunity of tissue-resident macrophages also enhances injury resolution to counterbalance the heightened inflammatory responses. Here, we studied lung-resident alveolar macrophages (AMs) prechallenged with either the bacterial endotoxin or with Pseudomonas aeruginosa and observed that these trained AMs showed greater resilience to pathogen-induced cell death. Transcriptomic analysis and functional assays showed greater capacity of trained AMs for efferocytosis of cellular debris and injury resolution. Single-cell high-dimensional mass cytometry analysis and lineage tracing demonstrated that training induces an expansion of a MERTKhiMarcohiCD163+F4/80low lung-resident AM subset with a proresolving phenotype. Reprogrammed AMs upregulated expression of the efferocytosis receptor MERTK mediated by the transcription factor KLF4. Adoptive transfer of these trained AMs restricted inflammatory lung injury in recipient mice exposed to lethal P. aeruginosa. Thus, our study has identified a subset of tissue-resident trained macrophages that prevent hyperinflammation and restore tissue homeostasis following repeated pathogen challenges.

Indexed as

Macrophages, AlveolarTrained ImmunityAdoptive TransferAnimalsc-Mer Tyrosine KinaseKruppel-Like Factor 4MicePhagocytosisc-Mer Tyrosine KinaseKlf4 protein, mouseKruppel-Like Factor 4Mertk protein, mouse

Identifiers

PMID37615937
PMCPMC10450795
OpenAlexW4386116435

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.